- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Meningococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Meningococcal Vaccine market size is estimated to be worth US$ 269.6 million in 2021 and is forecast to a readjusted size of USD 359.8 million by 2028 with a CAGR of 4.2% during review period. 6 Months-15Year accounting for % of the Meningococcal Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Meningtits A segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, and Baxter, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Meningococcal Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Market segment by Application can be divided into
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
The key market players for global Meningococcal Vaccine market are listed below:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccine, with price, sales, revenue and global market share of Meningococcal Vaccine from 2019 to 2022.
Chapter 3, the Meningococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Vaccine.
Chapter 13, 14, and 15, to describe Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Meningococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meningococcal Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Meningtits A
1.2.3 Polysaccharide Meningtitis AC
1.2.4 Meningitis ACYW
1.3 Market Analysis by Application
1.3.1 Overview: Global Meningococcal Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Global Meningococcal Vaccine Market Size & Forecast
1.4.1 Global Meningococcal Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Meningococcal Vaccine Sales in Volume (2017-2028)
1.4.3 Global Meningococcal Vaccine Price (2017-2028)
1.5 Global Meningococcal Vaccine Production Capacity Analysis
1.5.1 Global Meningococcal Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Meningococcal Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Meningococcal Vaccine Market Drivers
1.6.2 Meningococcal Vaccine Market Restraints
1.6.3 Meningococcal Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Meningococcal Vaccine Product and Services
2.1.4 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Meningococcal Vaccine Product and Services
2.2.4 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Meningococcal Vaccine Product and Services
2.3.4 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Meningococcal Vaccine Product and Services
2.4.4 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business
2.5.3 Baxter Meningococcal Vaccine Product and Services
2.5.4 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 JN International Medical Corporation
2.6.1 JN International Medical Corporation Details
2.6.2 JN International Medical Corporation Major Business
2.6.3 JN International Medical Corporation Meningococcal Vaccine Product and Services
2.6.4 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Meningococcal Vaccine Product and Services
2.7.4 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Meningococcal Vaccine Product and Services
2.8.4 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 China National Biotec Group
2.9.1 China National Biotec Group Details
2.9.2 China National Biotec Group Major Business
2.9.3 China National Biotec Group Meningococcal Vaccine Product and Services
2.9.4 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hualan Bio
2.10.1 Hualan Bio Details
2.10.2 Hualan Bio Major Business
2.10.3 Hualan Bio Meningococcal Vaccine Product and Services
2.10.4 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Walvax
2.11.1 Walvax Details
2.11.2 Walvax Major Business
2.11.3 Walvax Meningococcal Vaccine Product and Services
2.11.4 Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zhifei
2.12.1 Zhifei Details
2.12.2 Zhifei Major Business
2.12.3 Zhifei Meningococcal Vaccine Product and Services
2.12.4 Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Meningococcal Vaccine Breakdown Data by Manufacturer
3.1 Global Meningococcal Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Meningococcal Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Meningococcal Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Meningococcal Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Meningococcal Vaccine Manufacturer Market Share in 2021
3.5 Global Meningococcal Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Meningococcal Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Meningococcal Vaccine Market Size by Region
4.1.1 Global Meningococcal Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Meningococcal Vaccine Revenue by Region (2017-2028)
4.2 North America Meningococcal Vaccine Revenue (2017-2028)
4.3 Europe Meningococcal Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Meningococcal Vaccine Revenue (2017-2028)
4.5 South America Meningococcal Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Meningococcal Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Meningococcal Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Meningococcal Vaccine Revenue by Type (2017-2028)
5.3 Global Meningococcal Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Meningococcal Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Meningococcal Vaccine Revenue by Application (2017-2028)
6.3 Global Meningococcal Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Meningococcal Vaccine Sales by Type (2017-2028)
7.2 North America Meningococcal Vaccine Sales by Application (2017-2028)
7.3 North America Meningococcal Vaccine Market Size by Country
7.3.1 North America Meningococcal Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Meningococcal Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Meningococcal Vaccine Sales by Type (2017-2028)
8.2 Europe Meningococcal Vaccine Sales by Application (2017-2028)
8.3 Europe Meningococcal Vaccine Market Size by Country
8.3.1 Europe Meningococcal Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Meningococcal Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Meningococcal Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Meningococcal Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Meningococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Meningococcal Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Meningococcal Vaccine Sales by Type (2017-2028)
10.2 South America Meningococcal Vaccine Sales by Application (2017-2028)
10.3 South America Meningococcal Vaccine Market Size by Country
10.3.1 South America Meningococcal Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Meningococcal Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Meningococcal Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Meningococcal Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Meningococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Meningococcal Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Meningococcal Vaccine
12.3 Meningococcal Vaccine Production Process
12.4 Meningococcal Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Meningococcal Vaccine Typical Distributors
13.3 Meningococcal Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Meningococcal Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Meningococcal Vaccine Product and Services
Table 6. Novartis Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Meningococcal Vaccine Product and Services
Table 10. GSK Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Meningococcal Vaccine Product and Services
Table 14. Merck Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CSL Basic Information, Manufacturing Base and Competitors
Table 16. CSL Major Business
Table 17. CSL Meningococcal Vaccine Product and Services
Table 18. CSL Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Baxter Basic Information, Manufacturing Base and Competitors
Table 20. Baxter Major Business
Table 21. Baxter Meningococcal Vaccine Product and Services
Table 22. Baxter Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 24. JN International Medical Corporation Major Business
Table 25. JN International Medical Corporation Meningococcal Vaccine Product and Services
Table 26. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 28. Serum Institute of India Major Business
Table 29. Serum Institute of India Meningococcal Vaccine Product and Services
Table 30. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Meningococcal Vaccine Product and Services
Table 34. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 36. China National Biotec Group Major Business
Table 37. China National Biotec Group Meningococcal Vaccine Product and Services
Table 38. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 40. Hualan Bio Major Business
Table 41. Hualan Bio Meningococcal Vaccine Product and Services
Table 42. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Walvax Basic Information, Manufacturing Base and Competitors
Table 44. Walvax Major Business
Table 45. Walvax Meningococcal Vaccine Product and Services
Table 46. Walvax Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Zhifei Basic Information, Manufacturing Base and Competitors
Table 48. Zhifei Major Business
Table 49. Zhifei Meningococcal Vaccine Product and Services
Table 50. Zhifei Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Meningococcal Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (10K Pcs)
Table 52. Global Meningococcal Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Meningococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Meningococcal Vaccine Production Capacity by Company, (10K Pcs): 2020 VS 2021
Table 55. Head Office and Meningococcal Vaccine Production Site of Key Manufacturer
Table 56. Meningococcal Vaccine New Entrant and Capacity Expansion Plans
Table 57. Meningococcal Vaccine Mergers & Acquisitions in the Past Five Years
Table 58. Global Meningococcal Vaccine Sales by Region (2017-2022) & (10K Pcs)
Table 59. Global Meningococcal Vaccine Sales by Region (2023-2028) & (10K Pcs)
Table 60. Global Meningococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Meningococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
Table 63. Global Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
Table 64. Global Meningococcal Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Meningococcal Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Meningococcal Vaccine Price by Type (2017-2022) & (USD/Pcs)
Table 67. Global Meningococcal Vaccine Price by Type (2023-2028) & (USD/Pcs)
Table 68. Global Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
Table 69. Global Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
Table 70. Global Meningococcal Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Meningococcal Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Meningococcal Vaccine Price by Application (2017-2022) & (USD/Pcs)
Table 73. Global Meningococcal Vaccine Price by Application (2023-2028) & (USD/Pcs)
Table 74. North America Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
Table 75. North America Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
Table 76. North America Meningococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Meningococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
Table 79. North America Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
Table 80. North America Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
Table 81. North America Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
Table 82. Europe Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
Table 83. Europe Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
Table 84. Europe Meningococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Meningococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
Table 87. Europe Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
Table 88. Europe Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
Table 89. Europe Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
Table 90. Asia-Pacific Meningococcal Vaccine Sales by Region (2017-2022) & (10K Pcs)
Table 91. Asia-Pacific Meningococcal Vaccine Sales by Region (2023-2028) & (10K Pcs)
Table 92. Asia-Pacific Meningococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Meningococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
Table 95. Asia-Pacific Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
Table 96. Asia-Pacific Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
Table 97. Asia-Pacific Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
Table 98. South America Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
Table 99. South America Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
Table 100. South America Meningococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Meningococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
Table 103. South America Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
Table 104. South America Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
Table 105. South America Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
Table 106. Middle East & Africa Meningococcal Vaccine Sales by Region (2017-2022) & (10K Pcs)
Table 107. Middle East & Africa Meningococcal Vaccine Sales by Region (2023-2028) & (10K Pcs)
Table 108. Middle East & Africa Meningococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Meningococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
Table 111. Middle East & Africa Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
Table 112. Middle East & Africa Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
Table 113. Middle East & Africa Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
Table 114. Meningococcal Vaccine Raw Material
Table 115. Key Manufacturers of Meningococcal Vaccine Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Meningococcal Vaccine Typical Distributors
Table 119. Meningococcal Vaccine Typical Customers
List of Figures
Figure 1. Meningococcal Vaccine Picture
Figure 2. Global Meningococcal Vaccine Revenue Market Share by Type in 2021
Figure 3. Meningtits A
Figure 4. Polysaccharide Meningtitis AC
Figure 5. Meningitis ACYW
Figure 6. Global Meningococcal Vaccine Revenue Market Share by Application in 2021
Figure 7. 6 Months-15Year
Figure 8. over 3 Year
Figure 9. over 2 Year
Figure 10. over 3 Months
Figure 11. Global Meningococcal Vaccine Revenue, (USD Million) & (10K Pcs): 2017 & 2021 & 2028
Figure 12. Global Meningococcal Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Meningococcal Vaccine Sales (2017-2028) & (10K Pcs)
Figure 14. Global Meningococcal Vaccine Price (2017-2028) & (USD/Pcs)
Figure 15. Global Meningococcal Vaccine Production Capacity (2017-2028) & (10K Pcs)
Figure 16. Global Meningococcal Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Meningococcal Vaccine Market Drivers
Figure 18. Meningococcal Vaccine Market Restraints
Figure 19. Meningococcal Vaccine Market Trends
Figure 20. Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2021
Figure 21. Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2021
Figure 22. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Meningococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 26. Global Meningococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 27. North America Meningococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Europe Meningococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Meningococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. South America Meningococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Meningococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. Global Meningococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 33. Global Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. Global Meningococcal Vaccine Price by Type (2017-2028) & (USD/Pcs)
Figure 35. Global Meningococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 36. Global Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. Global Meningococcal Vaccine Price by Application (2017-2028) & (USD/Pcs)
Figure 38. North America Meningococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 39. North America Meningococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 40. North America Meningococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 41. North America Meningococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 42. United States Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Meningococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 46. Europe Meningococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 47. Europe Meningococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 48. Europe Meningococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 49. Germany Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Meningococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Meningococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Meningococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Meningococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 58. China Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Meningococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 65. South America Meningococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 66. South America Meningococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 67. South America Meningococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Meningococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Meningococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Meningococcal Vaccine in 2021
Figure 79. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 80. Meningococcal Vaccine Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
